Daniel Abdun-Nabi, Chief Executive Officer at Emergent BioSolutions Inc. (EBS), sold 15,785 shares at $52.11 ($823K) on 2018-06-05, disclosed to the SEC on 2018-06-07.
Open-market sale of $823k EBS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-01-04 | $1.0M | — | Filing → |
| EBS | SELL | 2017-12-14 | $920K | — | Filing → |